ICML 2019: "TELLOMAK” clinical trial design and rationale and KOL webcast
A KOL webcast and conference call was held on Thursday, June 20, 2019
Welcome to Innate Pharma
Scroll
About Innate Pharma
Innate Pharma S.A. is a commercial stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Headlines
Publication in Cell on innovative multifunctional NKp46 NK cell engagers (NKCEs)
May 31, 2019
Innate Pharma SA announced the publication of data demonstrating the potential of multifunctional NKp46 NKCEs in cancer immunotherapy in Cell
Innate Pharma SA announced the publication of data demonstrating the potential of multifunctional NKp46 NKCEs in cancer immunotherapy in Cell
Publication on next generation immunotherapies targeting the adenosine pathway in “Cell Reports”
" Blocking antibodies targeting the CD39/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies ” appeared in the online issue of Cell Reports on May 21st, 2019.
Upcoming events
ICML 2019 | Lugano, Switzerland
June 18, 2019 to June 22, 2019
ESMO Congress 2019 | Barcelona, Spain
September 27, 2019 to October 1, 2019
SITC 2019 | National Harbor, USA
November 6, 2019 to November 10, 2019